- Home
- BCLI vs MFI Comparison
BCLI vs MFI Comparison
Compare BCLI & MFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- MFI
- Stock Information
- Founded
- BCLI 2000
- MFI 2002
- Country
- BCLI United States
- MFI Hong Kong
- Employees
- BCLI N/A
- MFI N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- MFI
- Sector
- BCLI Health Care
- MFI
- Exchange
- BCLI Nasdaq
- MFI NYSE
- Market Cap
- BCLI 9.8M
- MFI 8.2M
- IPO Year
- BCLI N/A
- MFI 2024
- Fundamental
- Price
- BCLI $1.08
- MFI $5.26
- Analyst Decision
- BCLI Strong Buy
- MFI
- Analyst Count
- BCLI 1
- MFI 0
- Target Price
- BCLI $30.00
- MFI N/A
- AVG Volume (30 Days)
- BCLI 473.4K
- MFI 2.7M
- Earning Date
- BCLI 08-13-2025
- MFI 04-23-2025
- Dividend Yield
- BCLI N/A
- MFI N/A
- EPS Growth
- BCLI N/A
- MFI N/A
- EPS
- BCLI N/A
- MFI N/A
- Revenue
- BCLI N/A
- MFI $3,358,264.00
- Revenue This Year
- BCLI N/A
- MFI N/A
- Revenue Next Year
- BCLI N/A
- MFI N/A
- P/E Ratio
- BCLI N/A
- MFI N/A
- Revenue Growth
- BCLI N/A
- MFI N/A
- 52 Week Low
- BCLI $0.72
- MFI $0.51
- 52 Week High
- BCLI $6.45
- MFI $6.95
- Technical
- Relative Strength Index (RSI)
- BCLI 43.20
- MFI N/A
- Support Level
- BCLI $1.08
- MFI N/A
- Resistance Level
- BCLI $1.32
- MFI N/A
- Average True Range (ATR)
- BCLI 0.10
- MFI 0.00
- MACD
- BCLI -0.01
- MFI 0.00
- Stochastic Oscillator
- BCLI 4.00
- MFI 0.00
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About MFI MF INTERNATIONAL LIMITED
mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via the internet or a platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.